Navigation Links
New discoveries in genetics of lung health
Date:9/25/2011

Scientists have for the first time discovered sixteen new sections of the genetic code that relate to lung health -- opening up the possibility for better prevention as well as treatment for lung diseases.

An international consortium of 175 scientists from 126 centres in Europe, the USA and Australia identified genetic variants associated with the health of the human lung. Their discovery sheds new light on the molecular basis of lung diseases like Chronic Obstructive Pulmonary Disease (COPD).

It is the first time that these sixteen common genetic variants have been definitely linked with lung function. Researchers say the new pathways discovered could be targeted by drugs.

The study was led by Professor Martin Tobin from the University of Leicester, and Professor Ian Hall from The University of Nottingham and Dr Stephanie London from the U.S. National Institute of Environmental Health Sciences.

The pioneering research involved a genetic study of 2.5 million genetic variants in each of 48,201 people across the world. A smaller number of the most promising variants were then studied in a further 46,411 individuals. The research, part-funded by the UK Medical Research Council (MRC) and the Wellcome Trust, is published today in Nature Genetics.

The recent discoveries build on research published by the same authors last year, bringing the total number of genetic variants associated with lung function to twenty six. The same authors also showed, in research published in the American Journal of Respiratory and Critical Care Medicine in June 2011, that variants which predict lung function also predict the disease, COPD.

Professor Martin Tobin, Professor of Genetic Epidemiology and Public Health & MRC Senior Clinical Fellow at the University of Leicester, said: "COPD - a progressive disease that makes it hard for people to breathe - affects around 1 in 10 adults above the age of 40 and is fourth most common cause of death worldwide.

"Smoking is the most important risk for developing COPD. Smokers are not all equally likely to develop COPD and differences in susceptibility occur due to the genetic variants people carry. For the first time we understand what so many of these genetic variants are, including the underlying mechanisms that they point to. We now need to prioritise research to better understand these disease mechanisms and inform improved patient care.

"These discoveries could provide the key to new therapies for lung diseases such as COPD. It is too early to say whether this information would be of use as a screening test to predict the development of COPD. Stopping smoking is the best way to prevent COPD.

Professor Ian Hall said "This work is important because until recently we have not understood the factors which underlie inherited variability in lung function. The very large genetic studies required to identify key genes would not have been possible without the support of many groups around the world and the input of thousands of subjects. We now need to take the knowledge gained from this study to do two things: firstly to learn more about the function of genes which contribute to the risk of developing lung diseases such as COPD, and secondly to try and develop strategies to use genetic information to improve the clinical care provided to individual patients."


'/>"/>

Contact: Dr Martin Tobin
mt47@leicester.ac.uk
44-011-622-97270
University of Leicester
Source:Eurekalert

Related biology news :

1. Breakthrough lights way for RNA discoveries
2. Grants awarded to help bring promising bioscience discoveries to market
3. Discoveries in mitochondria open new field of cancer research
4. Drugs from the sea: New discoveries in marine biomedicine
5. Researcher to present discoveries on medical uses of ultrasound to Londons Royal Society
6. Researcher to present discoveries on medical uses of ultrasound to London’s Royal Society
7. Pivotal discoveries in age-related macular degeneration
8. New discoveries improve climate models
9. New discoveries make it harder for HIV to hide from drugs
10. UTHealth discoveries shed more light on deadly thoracic aortic disease
11. New discoveries in North Americas Great Plains bring ammonites to life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... 2017  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announces the appointment ... "Too often, too many offenders return to ... are trying to tackle this ongoing problem and ... family members. While significant steps are underway, Securus continues ...
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... , ... March 28, 2017 , ... ... a Marketing Roundtable on March 22 in Philadelphia. The event was offered by ... The Marketing Roundtable featured breakout groups and interaction with speakers who ...
(Date:3/28/2017)... , March 28, 2017 Volition America, Inc., a ... announced the engagement of Deborah Vollmer Dahlke , DrPH, ... consultant. Dr. Vollmer Dahlke,s role will be to ... the State of Texas and elsewhere ... Vollmer Dahlke has significant experience over the past six ...
(Date:3/28/2017)... ... March 28, 2017 , ... LabKey and collaborator Just ... software solution, LabKey Biologics . Built in collaboration with Just and designed ... Biologics provides drug research teams tools for biological entity registration, assay data integration, ...
(Date:3/28/2017)... Research Triangle Park, NC (PRWEB) , ... March ... ... drug development company engaged in the development of a new orally administered treatment ... Company’s Advisory Board. , CEO John Didsbury states, “As we seek to uniquely ...
Breaking Biology Technology: